Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19

Abroad (travel likely)RecruitingPHASE2

Conditions

SARS-CoV Infection · COVID-19

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Texas Southwestern Medical Center, Dallas, Texas, United States
Contact: Study coordinator (Theodoros Kelesidis, MD, PhD, Msc) · Theodoros.Kelesidis@UTSouthwestern.edu · 214-648-3486

Study leads

Theodoros Kelesidis, MD, PHD, Msc
Principal Investigator
University of Texas Southwestern Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS

Post-Acute COVID-19 Syndrome · Postural Tachycardia Syndrome (POTS) · SARS CoV 2 Infection

Abroad (travel likely)RecruitingPHASE2

Nashville, United States

Imaging Immune Activation in COVID-19

Covid19 · SARS-CoV Infection

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States

Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2

SARS-CoV-2 Infection · COVID-19 · Coronavirus

Abroad (travel likely)Recruiting

Nîmes, France · Nîmes, France

Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19

Long COVID-19 Syndrome · COVID 19 · Noncommunicable Disease

Abroad (travel likely)Recruiting

Bogotá, Colombia